Knock-down the clock gene can lead to colon carcinoma CT26 cell proliferation arrest through p53-dependent pathway and c-myc gene

References

• Al-Halabi R, Abou MR, Chakilam S, El-Baba C, Hamade E, Di Fazio P, Ocker M, Schneider-Stock R, Gali-Muhtasib H. 2015. Gallotannin is a DNA damaging compound that induces senescence independently of p53 and p21 in human colon cancer cells. Mol Carcinog. 54(10):1037–1050.
   PubMed Web of Science ®Google Scholar
• Bertheault-Cvitkovic F, Jami A, Ithzaki M, Brummer PD, Brienza S, Adam R, Kunstlinger F, Bismuth H, Misset JL, Lévi F. 1996. Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 14(11):2950–2958.
   PubMed Web of Science ®Google Scholar
• Chen-Goodspeed M, Lee CC. 2007. Tumor suppression and circadian function. J Biol Rhythms. 22:291–298. 3.
   PubMed Web of Science ®Google Scholar
• Deng X Q, Liu B A, Yang J, ZhangDeng YL. 2010. Expression of hClock and hBmal1 in human colorectal tumor. Cancer Research on Prevention and Treatment. 37(11):1288-1291.
   Google Scholar
• Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Ann Rev Physiol. 72:517–549.
   PubMed Web of Science ®Google Scholar
• Dimaki M, Xouri G, Symeonidou IE, Sirinian C, Nishitani H, Taraviras S, Lygerou Z. 2013. Cell cycle-dependent subcellular translocation of the human DNA licensing inhibitor geminin. J Biol Chem. 288(33):23953–23963.
   PubMed Web of Science ®Google Scholar
• Doi M, Hirayama J, Sassone-Corsi P. 2006. Circadian regulator CLOCK is a histone acetltransferase. Cell. 125:497–508.
   PubMed Web of Science ®Google Scholar
• Goldwasser F, Bae I, Valenti M, Torres K, Pommier Y. 1995. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. Cancer Res. 55(10):2116.
   PubMed Web of Science ®Google Scholar
• Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. 2005. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci U S A. 102(9):3407.
   PubMed Web of Science ®Google Scholar
• Greene MW. 2012. Circadian rhythms and tumor growth. Cancer Lett. 318(2):115.
   PubMed Web of Science ®Google Scholar
• Hu M-L, Yeh K-T, Lin P-M, Hsu C-M, Hsiao -H-H, Liu Y-C, Lin -HY-H, Lin S-F, Yang M-Y. 2014. Deregulated expression of circadian clock genes in gastric cancer. BMC Gastroenterol. 14:67–75.
   PubMed Web of Science ®Google Scholar
• Jiang W, Zhao S, Jiang X, Zhang E, Hu G, Hu B, Zheng P, Xiao J, Lu Z, Lu Y, et al. 2015. The circadian clock gene bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Cancer Lett. 371(2):314–325.
   PubMed Web of Science ®Google Scholar
• Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Lymberi M, Pektasides D. 2013. Expression of clock genes in patients with colorectal cancer. Int J Biol Markers. 28:280–285.
   PubMed Web of Science ®Google Scholar
• Ko CH, Takahashi JS. 2006. Molecular components of the mammalian circadian clock. Hum Mol Genet. 15(Spec No.2):R271–R277.
   PubMedGoogle Scholar
• Köhler A, Hellweg S, Recan E, Hungerbühler K. 2007. Input-dependent life-cycle inventory model of industrial wastewater-treatment processes in the chemical sector. Environ Sci Technol. 41(15):5515.
   PubMed Web of Science ®Google Scholar
• Krugluger W, Brandstaetter A, Kállay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. 2007. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 67(16):7917–7922.
   PubMed Web of Science ®Google Scholar
• Long BH, Fairchild CR. 1994. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res. 54(16):4355.
   PubMed Web of Science ®Google Scholar
• Lunagariya J, Liao X, Long W, Zhong S, Bhadja P, Li H, Zhao B, Xu S. 2017. Cytotoxicity study of cyclopentapeptide analogues of marine natural product galaxamide towards human breast cancer cells. Oxidative Med Cell Longevity. 2017(3):1–13.
   Google Scholar
• Martineau-Pivoteau N, Levi F, Rolhion C, Kwiatkowski F, Lemaigre G, Filipski E, Chollet P. 1996. Circadian rhythm in toxic effects of cystemustine in mice: relevance for chronomodulated delivery. Int J Cancer J Int Du Cancer. 68(5):669–674.
   PubMed Web of Science ®Google Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. 2003. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 302(5643):255–259.
   PubMed Web of Science ®Google Scholar
• Mostafaie N, Kállay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W. 2009. Correlated downregulation of estrogen receptor beta and the circadian clock gene per1 in human colorectal cancer. Mol Carcinog. 48(7):642.
   PubMed Web of Science ®Google Scholar
• Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, Nozaki A, Numata K, Shiozawa M, Rino Y, Tanaka K. 2011. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep. 25: 1439–1446. 20.
   PubMed Web of Science ®Google Scholar
• Rey G. 2013. Reddy AB: connecting cellular metabolism to circadian clocks. Trends Cell Biol. 23:234–241.
   PubMed Web of Science ®Google Scholar
• Sakamoto W, Takenoshita S. 2015. Overexpression of both clock and bmal1 inhibits entry to s phase in human colon cancer cells. Fukushima J Med Sci. 61(2):111.
   PubMedGoogle Scholar
• Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. 2003 Jun 4. Night-shift work and risk of colorectal cancer in the nurses’ health study. J Natl Cancer Inst. 95:825–828.
   PubMed Web of Science ®Google Scholar
• Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, et al. 2007. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA. 104:18654–18659.
   PubMed Web of Science ®Google Scholar
• Smith G, Carey FA, Beattie J, Wilkie MJV, Lightfoot TJ, Coxhead J, Garner RC, Steele RJC, Wolf CR. 2002. Mutations in APC, Kirstenras, and p53–alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA. 99:9433–9438.
   PubMed Web of Science ®Google Scholar
• Štorcelová M, Vicián M, Reis R, Zeman M, Herichová I. 2013. Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue. Mol Biol Rep. 40(11):6351–6361.
   PubMed Web of Science ®Google Scholar
• Viswanathan AN, Hankinson SE, Schernhammer ES. 2007 Nov 1. Night shift work and the risk of endometrial cancer. Cancer Res. 67:10618–10622.
   PubMed Web of Science ®Google Scholar
• Wang L, Chen B, Wang Y, Sun N, Lu C, Qian R, Hua L. 2013. hClock gene expression in human colorectal carcinoma. Mol Med Rep. 8(4):1017.).
   Web of Science ®Google Scholar
• Wang Y, Qian R, Sun N, Lu C, Chen Z, Hua L. 2015. Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo. Mol Med Rep. 11(6):4204.
   PubMed Web of Science ®Google Scholar
• Zeng ZL, Luo HY, Yang J, Wu W-J, Chen D-L, Huang P, Xu R-H. 2014. Overexpression of the circadian clock gene bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 20(4):1042–1052.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. 2006. Does “Clock” matter in prostate cancer? Cancer Epidemiol Biomarkers Prev. 15:3–5.
   PubMed Web of Science ®Google Scholar